FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070590 [Registered on: 15/07/2024] Trial Registered Prospectively
Last Modified On: 12/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Study of effect of Gokshur kwath and Yavakshar in recurrent urinary tract infections and to study its antimicrobial effect 
Scientific Title of Study   Randomized controlled trial and assessment of antimicrobial effect of Gokshur kwath and Yavakshar in mootrakrichchhra with special reference to recurrent urinary tract infections.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Smita Pandey 
Designation  Junior Resident 
Affiliation  BHU 
Address  Department of Shalya Tantra Faculty of Ayurveda IMS BHU Varanasi Sir Sunderlal Hospital faculty of Ayurveda IMS BHU Varanasi UTTAR PRADESH

Varanasi
UTTAR PRADESH
221005
India 
Phone  7860055603  
Fax    
Email  smitapandeyvns65@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Awadhesh Kumar Pandey 
Designation  Assistant Professor  
Affiliation  Banaras Hindu University  
Address  Department of Shalya Tantra Faculty of Ayurveda IMS BHU Varanasi Sir Sunderlal Hospital faculty of Ayurveda IMS BHU Varanasi UTTAR PRADESH

Varanasi
UTTAR PRADESH
221005
India 
Phone  7376887965  
Fax    
Email  awadheshoct20@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Deepak Kumar  
Designation  Associate Professor  
Affiliation  Banaras Hindu University  
Address  Department of Microbiology Faculty of Modern Medicine Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh

Varanasi
UTTAR PRADESH
221005
India 
Phone  9451354332  
Fax    
Email  deepakkumar.micro@bhu.ac.in  
 
Source of Monetary or Material Support  
Sir Sunderlal Hospital Faculty of Ayurveda Institute of Medical Sciences IMS BHU Varanasi 221005 Uttar Pradesh India 
 
Primary Sponsor  
Name  Department of Shalya Tantra Faculty of Ayurveda Insitute of Medical Sciences 
Address  Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh 221005 India  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Awadhesh Kumar Pandey  Sir Sundarlal hospital BHU  OPD No.12,14,16A Indian Medicine Wing Department of Shalya Tantra Faculty of Ayurveda Institute of Medical Sciences BHU Varanasi UTTAR PRADESH Varanasi UTTAR PRADESH
Varanasi
UTTAR PRADESH 
7376887965

awadheshoct20@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Institute of Medical Sciences, Banaras Hindu University  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N390||Urinary tract infection, site notspecified. Ayurveda Condition: MUTRAKRUCCRAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: yavakshar, Reference: bhaishajya ratnavali chapter no 34 verse no 19, Route: Oral, Dosage Form: Kshara , Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -gokshura kwath), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: gokshur, Reference: bhaishajya ratnavali chapter no. 34 and verse no. 19, , Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 1 Months, anupAna/sahapAna: No, Additional Information: -yavakshar 500 mg capsule BID is given along with gokshur kwath
3Comparator Arm (Non Ayurveda)-NITROFURANTOINStandard modern medication will be administered i.e. Nitrofurantoin 100mg 1 T.D.S. for 15 days.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Adult male and female subjects of age 18-60 yrs having symptoms of Mootrakrichchhra such as Bastishul (pain in lower abdomen)/Muhurmuhurmootrata(frequent micturition)/ Sadaahmootrata (burning micturition)/Krichchhrapravrutti of Mootravahana/ Sarujamootrata (painful micturition/dysuria)and with positive urine culture and sensitive to nitrofurantoin.
Patients having symptoms of recurrent Urinary tract infections i.e. 3 or more culture proven infections within a 12 months period, or as 2 or more culture proven infections in a 6 months period
Subjects willing to sign informed consent and follow the study procedure.
 
 
ExclusionCriteria 
Details  Subjects having symptoms of mootraghat such as vibandh of mootra (obstructive flow of urine, saraktmootrata (gross hematuria), mootrasang (stricture of urethra)vatashthila (enlarged prostate).
Subjects of age group less than 18 years and more than 60 years.
Complicated Urinary tract infections like Catheterization, anatomic and functional abnormalities, immune suppression, renal disease, renal calculi, pyelonephritis, neurogenic bladder)
History of interstitial cystitis,bph,Urothelial cancer
Pregnancy
STDs ,Tuberculosis affecting the bladder.
HIV, Anti-HCV &, HBsAg positive subjects.
Patient suffering from any other systemic diseases
Uncontrolled Hypertension
Uncontrolled Diabetes mellitus
T.B
Malignancy
Patients with sterile urine specimen.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in symptoms like-
Bastishul (pain in lower abdomen)
Muhurmuhurmootrata(frequent micturition)
Sadaahmootrata (burning micturition) Krichchhrapravrutti of Mootravahana/ Sarujamootrata (painful micturition/dysuria) 
2 months 
 
Secondary Outcome  
Outcome  TimePoints 
To study the antimicrobial effect of Gokshur Kwath and Yavakshar   2 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   30/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Conventional antibiotics are the first choice in an acute episode of UTI; therefore, resistance of pathogenic bacteria to antibiotics is of high clinical concern. The concept of the control of drug resistance is rather widely held today. Therefore the world looks at some alternative and effective medicine particularly of natural origin. In Ayurvedic texts various acharyas mentioned the shodhana and Shaman chikitsa for it. The Gokshurkwath and Yavakshar are mentioned as mootrakrichchhrahara in Bhashajya Ratnavali. Hence, the present study aims to explore the efficacy of therapeutic and antimicrobial effect of Gokshurkwatha and Yavakshar in the management of mootrakrichchhra with special reference to recurrent Urinary tract infections.

60 cases of mootrakrichhra will be included in this interventional study which will be randomly divided into 2  groups of 30 patients in each group. One group will be prescribed gokshura kwath 40ml and yavakshar 500 mg BD for 30 days .Second group will be prescribed nitrofurantoin 100mg TDS for 15 days after doing urine culture and sesitivity .The study will be conducted for 60 days with 4 follow up after every 15 days.

 
Close